Your browser doesn't support javascript.
loading
Metabolic Reprogramming Drives Pituitary Tumor Growth through Epigenetic Regulation of TERT.
Onizuka, Hiromi; Masui, Kenta; Amano, Kosaku; Kawamata, Takakazu; Yamamoto, Tomoko; Nagashima, Yoji; Shibata, Noriyuki.
Afiliação
  • Onizuka H; Department of Surgical Pathology, Tokyo Women's Medical University, Shinjuku, Tokyo 162-8666, Japan.
  • Masui K; Division of Pathological Neuroscience, Department of Pathology, Tokyo Women's Medical University, Shinjuku, Tokyo 162-8666, Japan.
  • Amano K; Division of Pathological Neuroscience, Department of Pathology, Tokyo Women's Medical University, Shinjuku, Tokyo 162-8666, Japan.
  • Kawamata T; Department of Neurosurgery, Tokyo Women's Medical University, Shinjuku, Tokyo 162-8666, Japan.
  • Yamamoto T; Department of Neurosurgery, Tokyo Women's Medical University, Shinjuku, Tokyo 162-8666, Japan.
  • Nagashima Y; Department of Surgical Pathology, Tokyo Women's Medical University, Shinjuku, Tokyo 162-8666, Japan.
  • Shibata N; Division of Pathological Neuroscience, Department of Pathology, Tokyo Women's Medical University, Shinjuku, Tokyo 162-8666, Japan.
Acta Histochem Cytochem ; 54(3): 87-96, 2021 Jun 29.
Article em En | MEDLINE | ID: mdl-34276102
ABSTRACT
Pituitary adenomas are common, benign brain tumors. Some tumors show aggressive phenotypes including early recurrence, local invasion and distant metastasis, but the underlying mechanism to drive the progression of pituitary tumors has remained to be clarified. Aerobic glycolysis known as the Warburg effect is one of the emerging hallmarks of cancer, which has an impact on the tumor biology partly through epigenetic regulation of the tumor-promoting genes. Here, we demonstrate metabolic reprogramming in pituitary tumors contributes to tumor cell growth with epigenetic changes such as histone acetylation. Notably, a shift in histone acetylation increases the expression of telomerase reverse transcriptase (TERT) oncogene, which drives metabolism-dependent cell proliferation in pituitary tumors. These indicate that epigenetic changes could be the specific biomarker for predicting the behavior of pituitary tumors and exploitable as a novel target for the aggressive types of the pituitary tumors.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Acta Histochem Cytochem Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Acta Histochem Cytochem Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão